ConductScience.org, home

Trial · NCT01931098

Adverse events230

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherAbdominal painGastrointestinal disordersGlioblastoma or Gliosarcoma With No Prior Bevacizumab Exposure090
otherAbdominal painGastrointestinal disordersGlioblastoma or Gliosarcoma With Prior Bevacizumab Exposure2263
otherAlanine aminotransferase increasedInvestigationsGlioblastoma or Gliosarcoma With No Prior Bevacizumab Exposure192
otherAlanine aminotransferase increasedInvestigationsGlioblastoma or Gliosarcoma With Prior Bevacizumab Exposure2262
otherAnemiaBlood and lymphatic system disordersGlioblastoma or Gliosarcoma With No Prior Bevacizumab Exposure191
otherAnemiaBlood and lymphatic system disordersGlioblastoma or Gliosarcoma With Prior Bevacizumab Exposure2262
otherAnorexiaMetabolism and nutrition disordersGlioblastoma or Gliosarcoma With No Prior Bevacizumab Exposure292
otherAnorexiaMetabolism and nutrition disordersGlioblastoma or Gliosarcoma With Prior Bevacizumab Exposure6266
otherAnxietyPsychiatric disordersGlioblastoma or Gliosarcoma With No Prior Bevacizumab Exposure090
otherAnxietyPsychiatric disordersGlioblastoma or Gliosarcoma With Prior Bevacizumab Exposure1261
otherArthralgiaMusculoskeletal and connective tissue disordersGlioblastoma or Gliosarcoma With No Prior Bevacizumab Exposure191
otherArthralgiaMusculoskeletal and connective tissue disordersGlioblastoma or Gliosarcoma With Prior Bevacizumab Exposure1261
otherAspartate aminotransferase increasedInvestigationsGlioblastoma or Gliosarcoma With No Prior Bevacizumab Exposure192
otherAspartate aminotransferase increasedInvestigationsGlioblastoma or Gliosarcoma With Prior Bevacizumab Exposure1261
otherAtaxiaNervous system disordersGlioblastoma or Gliosarcoma With No Prior Bevacizumab Exposure090
otherAtaxiaNervous system disordersGlioblastoma or Gliosarcoma With Prior Bevacizumab Exposure1261
otherBladder infectionInfections and infestationsGlioblastoma or Gliosarcoma With No Prior Bevacizumab Exposure090
otherBladder infectionInfections and infestationsGlioblastoma or Gliosarcoma With Prior Bevacizumab Exposure1261
otherBlood and lymphatic system disorders - Other, Blood in stoolBlood and lymphatic system disordersGlioblastoma or Gliosarcoma With No Prior Bevacizumab Exposure090
otherBlood and lymphatic system disorders - Other, Blood in stoolBlood and lymphatic system disordersGlioblastoma or Gliosarcoma With Prior Bevacizumab Exposure1261

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01931098/events